AstraZeneca’s Durvalumab Treatment Receives Fast-Track Approval
The most of promising cancer drug developed by AstraZeneca, will speed up its research under FDA’s guidance.
Durvalumab
The most of promising cancer drug developed by AstraZeneca, will speed up its research under FDA’s guidance.
